Stock Events

Stock Events

SMS Pharmaceuticals 

₹398.30
3
+₹0.35+0.09% 10:00 Today

Statistics

Day High
409.4
Day Low
394.15
52W High
447.8
52W Low
242.25
Volume
634,479
Avg. Volume
392,633
Mkt Cap
37.3B
P/E Ratio
35.86
Dividend Yield
0.1%
Dividend
0.4

Upcoming

Dividends

0.1%Dividend Yield
Sep 26
₹0.40
Oct 25
₹0.40
Oct 24
₹0.40
Oct 23
₹0.30
Oct 22
₹0.30
10Y Growth
7.18%
5Y Growth
N/A
3Y Growth
10.06%
1Y Growth
N/A

Earnings

22MayExpected
Q3 2022
Q4 2022
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
999
333
-333
-999
Expected EPS
N/A
Actual EPS
N/A

Financials

11.15%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
13.25BRevenue
1.48BNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow SMSPHARMA.NSE. It's not an investment recommendation.
Indian Renewable Energy Development Agency
2
IREDA.NSE
Housing & Urban Development
2
HUDCO.NSE
Confidence Petroleum India
2
CONFIPET.NSE
Thirumalai Chemicals
2
TIRUMALCHM.NSE

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Aurobindo Pharma
AUROPHARMA.NSE
Mkt Cap891.43B
Aurobindo Pharma manufactures generic pharmaceuticals and APIs, directly competing in similar markets as SMS Pharmaceuticals.
Divi`s Laboratories
DIVISLAB.NSE
Mkt Cap1.81T
Divi's Laboratories specializes in APIs and intermediates, competing in the same segment as SMS Pharmaceuticals.
Dr. Reddy`s Laboratories
DRREDDY.NSE
Mkt Cap1.04T
Dr. Reddy's Laboratories is a major player in the production of generic pharmaceuticals and APIs, overlapping with SMS Pharmaceuticals' market.
Cipla
CIPLA.NSE
Mkt Cap1.16T
Cipla produces a range of pharmaceuticals and APIs, serving similar markets as SMS Pharmaceuticals.
Lupin
LUPIN.NSE
Mkt Cap1.14T
Lupin manufactures a broad array of generic drugs and APIs, directly competing with SMS Pharmaceuticals.
Sun Pharmaceutical Industries
SUNPHARMA.NSE
Mkt Cap4.64T
Sun Pharmaceutical Industries is a leader in generic pharmaceuticals and APIs, competing in the same niche as SMS Pharmaceuticals.
Glenmark Pharmaceuticals
GLENMARK.NSE
Mkt Cap649.43B
Glenmark Pharmaceuticals focuses on generics and specialty drugs, including APIs, competing in similar areas as SMS Pharmaceuticals.
Alkem Laboratories
ALKEM.NSE
Mkt Cap665.62B
Alkem Laboratories is known for its generic drug formulations and active pharmaceutical ingredients, competing with SMS Pharmaceuticals.
Biocon
BIOCON.NSE
Mkt Cap681.44B
Biocon is involved in biopharmaceuticals and APIs, which places it in competition with SMS Pharmaceuticals in the API segment.

About

SMS Pharmaceuticals Limited, an Indian company established in 1987 and based in Hyderabad, specializes in the production and distribution of active pharmaceutical ingredients (APIs) and pharmaceutical intermediates. The firm offers a wide array of APIs targeting various therapeutic categories, including anti-ulcer, anti-fungal, anti-migraine, anti-diabetic, erectile dysfunction, antiemetic, antiepileptic, antipsychotic, anti-hypertensive, anti-anginal, anti-viral, urinary antispasmodic, and anti-retroviral applications. Furthermore, SMS Pharmaceuticals engages in contract research activities and exports its products globally.
Show more...
CEO
Ramesh Babu Potluri
Employees
1197
Country
India
ISIN
INE812G01025

Listings

NSE
IN
SMSPHARMA.NSE

0 Comments

Share your thoughts

FAQ

What is SMS Pharmaceuticals stock price today?▼
The current price of SMSPHARMA.NSE is ₹398.30 INR — it has increased by +0.09% in the past 24 hours. Watch SMS Pharmaceuticals stock price performance more closely on the chart.
What is SMS Pharmaceuticals stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on NSE (India) exchange SMS Pharmaceuticals stocks are traded under the ticker SMSPHARMA.NSE.
Is SMS Pharmaceuticals stock price growing?▼
SMSPHARMA.NSE stock has risen by +8.16% compared to the previous week, the month change is a +5.34% rise, over the last year SMS Pharmaceuticals has showed a +63.91% increase.
What is SMS Pharmaceuticals market cap?▼
Today SMS Pharmaceuticals has the market capitalization of 37.3B
What is SMS Pharmaceuticals revenue for the last year?▼
SMS Pharmaceuticals revenue for the last year amounts to 13.25B INR.
What is SMS Pharmaceuticals net income for the last year?▼
SMSPHARMA.NSE net income for the last year is 1.48B INR.
Does SMS Pharmaceuticals pay dividends?▼
Yes, SMSPHARMA.NSE dividends are paid annual. The last dividend per share was 0.4 INR. As of today, Dividend Yield (FWD)% is 0.1%.
How many employees does SMS Pharmaceuticals have?▼
As of September 08, 2026, the company has 1,197 employees.
In which sector is SMS Pharmaceuticals located?▼
SMS Pharmaceuticals operates in the Health & Wellness sector.
When did SMS Pharmaceuticals complete a stock split?▼
The last stock split for SMS Pharmaceuticals was on December 17, 2015 with a ratio of 10:1.
Where is SMS Pharmaceuticals headquartered?▼
SMS Pharmaceuticals is headquartered in Hyderabad, India.